Abstract

The clinical impact of anticoagulant-related major bleeding in patients with venous thromboembolism is considerable, and clinicians should take this into account when deciding whether to continue long-term oral anticoagulant therapy in an individual patient.

Keywords

MedicineAnticoagulantCase fatality rateProspective cohort studyRandomized controlled trialCohort studySurgeryInternal medicineEpidemiology

MeSH Terms

AdministrationOralAnticoagulantsDrug Administration ScheduleHemorrhageHumansIntracranial HemorrhagesProspective StudiesRandomized Controlled Trials as TopicRisk FactorsThromboembolismVenous Thrombosis

Affiliated Institutions

Related Publications

Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology

Oral antiplatelet drugs are a cornerstone of modern pharmacotherapy in cardiovascular atherothrombotic diseases. The efficacy of acetylsalicylic acid (ASA, aspirin) and clopidog...

2008 European Heart Journal 229 citations

Publication Info

Year
2003
Type
review
Volume
139
Issue
11
Pages
893-900
Citations
758
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

758
OpenAlex
20
Influential
607
CrossRef

Cite This

Lori‐Ann Linkins, P. Choi, James D. Douketis (2003). Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis.. PubMed , 139 (11) , 893-900. https://doi.org/10.7326/0003-4819-139-11-200312020-00007

Identifiers

DOI
10.7326/0003-4819-139-11-200312020-00007
PMID
14644891

Data Quality

Data completeness: 81%